HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials.

Dent S., Oyan B., Honig A., Mano M., Howell S.

Cancer treatment reviews, vol.39, pp.622-31, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 39
  • Publication Date: 2013
  • Doi Number: 10.1016/j.ctrv.2013.01.002
  • Journal Name: Cancer treatment reviews
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.622-31
  • Keywords: Neoadjuvant breast cancer, Pathological complete response, Trastuzumab, Lapatinib, Pertuzumab, Novel agents, HER2, PHASE-II TRIAL, PATHOLOGICAL COMPLETE RESPONSE, CHEMOTHERAPY PLUS TRASTUZUMAB, STAGE-II, OPEN-LABEL, PREOPERATIVE CHEMOTHERAPY, INDUCTION CHEMOTHERAPY, ADJUVANT TRASTUZUMAB, NAB-PACLITAXEL, DOCETAXEL
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No